Article Text

This article has a correction. Please see:

Reminder of important clinical lesson
Diffuse mesangial IgA glomerulonephritis in a patient with rheumatoid arthritis: a possible extra-articular manifestation in rheumatoid arthritis
  1. Lyubomir Marinchev1,
  2. Svetla Atanasova2,
  3. Raina Robeva2,
  4. Todor Todorov3
  1. 1
    University Hospital, Rheumatology, 13 Urvitch, Sofia, 1612, Bulgaria
  2. 2
    University Hospital “St. Ivan Rilsky”, Internal Medicine and Nephrology, 15 Ivan Geshov Boulevard, Sofia, 1431, Bulgaria
  3. 3
    University Hospital “Alexandrovska”, Pathology, 1 “Georgi Sofiiski” Street, Sofia, 1431, Bulgaria
  1. Lyubomir Marinchev, Lubommar{at}


Rheumatoid arthritis (RA) is an inflammatory joint disease, in which, unlike systemic lupus erythematosus (SLE), renal involvement is uncommon. The major causes of renal disease in RA are usually linked to amyloid or secondary effects of drugs. Nevertheless the relation between IgA, IgA-rheumatoid factor (RF) and renal disease in patients with RA is not clear, but the affinity of IgA for mesangium, skin and synovium might explain clinical presentation of RA with mesangial IgA glomerulonephritis. The case of a 42-year-old Caucasian man with RA and diffuse mesangial IgA glomerulonephritis proven by renal biopsy is presented. The patient was treated with boluses of methylprednisolone 1000 mg and cyclophosphamide 1000 mg monthly for 13 months. Between boluses there was a supported therapy with methylprednisolone 8 mg/day. After a year of treatment full clinical and laboratory remission of RA and IgA glomerulonephritis was achieved. Pathogenic therapy will be stopped and the patient followed-up.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Competing interests: None.

  • Patient consent: Patient/guardian consent was obtained for publication.